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Natural killer (NK) ceils lyse autologous and allogeneic target cells even in the absence of major 
histocompatibility complex (MHC) dass I antigens on the target cells. Recently, however, human 
allospecific NK cell clones have been generated that recognize at least five distinct specificities 
inherited recessively and controlled by genes linked to the MHC. Because the genetic specificity 
of these alloreactive NK cells in vitro appears analogous to that of in vivo NK cell-mediated 
murine hybrid resistance, i.e.,  the rejection of parental bone marrow in irradiated F1 animals, 
we tested the ability of human aUoreactive NK  clones to recognize allogeneic hematopoietic 
progenitor cells. NK cells from two specificity 1 alloreactive NK clones, ES9 and ES10, significantly 
and often completely suppressed colony formation by purified peripheral blood hematopoietic 
progenitor ceils from specificity 1-susceptible donors, but had no significant effect on the cells 
of specificity 1-resistant donors. Activated polyclonal NK cells were less efficient than the NK 
clones in inhibiting colony formation and had a similar effect on cells from both specificity 
1-susceptible  and -resistant  donors.  The  alloreactive NK  clones produced cytokines with  a 
suppressive effect on in vitro hematopoiesis, such as interferon 3, (IFN-'y) and tumor necrosis 
factor oe (TNF-o  0, when exposed to phytohemagglutinin blasts from specificity 1-susceptible, 
but not -resistant donors. However, the mechanism by which alloreactive NK cells inhibit colony 
formation is more consistent with a direct cytotoxic effect than with the production of inhibitory 
cytokines because antibodies (anti-IFN-% c~-TNF-ot, and -lymphotoxin) that completely blocked 
the inhibition by polyclonal NK cells had only a minimal effect on the inhibition by the allo- 
reactive clones. Moreover, the alloreactive clones were directly cytolytic in a SlCr release assay 
against enriched preparations of peripheral blood progenitor cells from specificity 1-susceptible 
donors. These data indicate that the alloreactive NK cells are likely the human counterpart of 
the cells mediating murine hybrid resistance and that these cells might play clinically important 
roles in rejection or in graft-versus-leukemia reactions after allogeneic bone marrow transplantation. 
N 
'K cells lyse in vitro a variety of target cells even in the 
absence  of MHC  antigens  on  the  target  cells.  NK 
cell-mediated killing, therefore, unlike TCR-mediated lysis, 
does not require MHC compatibility (1). Several lines of evi- 
dence, however, suggest that this non-MHC-restricted cyto- 
toxicity may not be completely independent of MHC  ex- 
pression on target cells. In several experimental systems it was 
shown that the susceptibility of cells to NK cell-mediated 
lysis is inversely proportional to their expression of class  I 
MHC antigens (2-6, and reviewed in reference 7). Cells from 
32-microglobulin-deficient mice do not express class I MHC 
antigens and are particularly sensitive to NK cell-mediated 
lysis; interestingly, NK cells from these animals are low in 
number and have a reduced lytic activity, suggesting that NK 
cells might be subjected to a negative selection mechanism 
in vivo, similarly to T  cells (8).  One of the hypotheses to 
explain this phenomenon is the "missing self hypothesis;' 
which postulates that one function of NK cells is to recog- 
nize and eliminate cells that do not express MHC class I mol- 
ecules (7).  Although this hypothesis is compatible with at 
least some of the experimental findings, the mechanism of 
class I recognition by NK cells has not been elucidated, and 
two alternative hypotheses are often considered: (a) the receptor 
inhibition hypothesis postulating that the presence of class 
I on target cells delivers a negative signal to the NK cells, 
or (b) the target interference hypothesis postulating that class 
I antigens or their associated peptides sterically mask recog- 
nition of an NK target structure on the target cells (9). The 
finding that the Ly-49 antigen present on a small subset of 
NK cells in certain mouse strains is associated with failure 
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indicates that NK cells may be capable of a fine recognition 
of class I  antigens (10). 
In the mouse, NK cells are the primary effectors of in vivo 
hybrid resistance,  i.e., the rejection of parental bone marrow 
grafts by lethally irradiated F1 hybrids (11, 12). Unlike lysis 
in vitro of tumor cells, this in vivo NK-mediated reaction 
is highly specific, genetically restricted, and directed at cel- 
lular determinants present on hematopoietic cells only. These 
determinants are proposed to be the products of a class of 
noncodominant  genes  (hematopoietic  histocompatibility 
[Hh] 1 genes), of which the main one, Hh-1,  maps to the 
MHC (H-2) between the S and D regions (13, 14). The ability 
of hematopoietic cells carrying relevant Hh-1 specificity to 
compete in vivo with hematopoietic progenitor cells and to 
suppress hybrid resistance (15) strongly suggests that NK cells 
are not only the effector cells of the resistance,  but are also 
directly responsible for the genetic specificity of this phenom- 
enon and can specifically recognize Hh-1. 
Although  there  is  no  evidence for  a  hybrid  resistance 
phenomenon or the existence of Hh-like genes in humans, 
recent  reports  documenting  the  ability  of MLC-derived 
CD3-,  CD16 +  clones  to  specifically  lyse  PHA-induced 
blasts generated from the stimulating donor and a propor- 
tion of allogeneic donors, but not those generated from au- 
tologous donors (16), point to the existence of a strikingly 
similar system. So far, at least five distinct NK allospecificities 
have been identified (17,  18). Genetic analysis  of these al- 
lospecificities indicated that the genes controlling the character 
"susceptibility to lysis" segregate independently, are inherited 
in an autosomal recessive mode, are linked to the MHC locus, 
and at least one of them maps in the MHC region between 
the BF complement cluster and the HLA-A locus (18-20). 
Thus, the genetic control of these specificities closely resembles 
that of Hh-1 observed in the murine system. The recent finding 
(21) that transfection of target cells with genomic DNA en- 
coding the class I antigen CW3 specifically prevents recog- 
nition by allospecificity 2 NK cell clones indicates that the 
character "resistance to lysis" is a dominant character. This, 
therefore, explains the observation of pedigree analysis that 
the phenotype "susceptibility to lysis" is inherited as a reces- 
sive trait. Although the specificity of alloreactive NK cell clones 
correlates with the expression of certain NK cell surface makers, 
suggesting a possible role of these surface structures in target 
recognition and/or interaction with class I (10, 17), the exact 
nature of the receptors involved in class I recognition, and 
whether class I antigens act by masking an NK recognition 
site or by delivering a negative signal, remains to be inves- 
tigated. 
Since the hybrid resistance phenomenon has been difficult 
to reproduce in vitro (22),  human NK clones may provide 
a useful tool to dissect events of potential relevance in the 
NK-mediated allogeneic recognition of hematopoietic cells. 
In the present study, using the two human alloreactive NK 
1 Abbreviations used in this paper: Hh, hematopoietic  histocompatibility;  LT, 
lymphotoxin; NKSF, natural killer cell stimulatory factor; PBHPC, 
peripheral blood hematopoietic  progenitor cell. 
dones, ES9 and ES10, both recognizing specifidty 1, we found 
that allorecognition of PHA blasts derived from donors car- 
rying specificity 1 induces IFN3, production by the NK clones, 
especially in synergy with other inducers, such as IL-2 and 
NK cell stimulatory factor (NKSF/IL-12). Moreover, the dones 
inhibit in vitro colony growth of hematopoietic progenitors 
from specificity 1-susceptible but not specificity 1-resistant 
donors. Antibodies against the hematopoietic inhibitory factors 
IFN-3', TNF-ot, and lymphotoxin (LT) only minimally pre- 
vented the inhibition of colony formation by the alloreactive 
clones, whereas they completely prevented the inhibition medi- 
ated by polyclonally activated NK cells or that of specificity 
1-resistant progenitors mediated by alloreactive NK clones 
in the presence of bystander specificity 1-susceptible PHA 
blasts. In SlCr release cytotoxic assays, alloreactive NK clones 
lysed both PHA blasts and enriched peripheral blood hema- 
topoietic progenitor cells (PBHPC) from specificity 1-suscep- 
tible but not -negative donors. These results suggest that 
the NK cell allospecificity 1 is expressed on hematopoietic 
precursor cells and that alloreactive NK cell clones can in- 
hibit colony growth with a direct cytotoxic mechanism. 
Materials and Methods 
Generation  of ES9 and ESIO Alloreactive  NK  Cell Clones.  ES9 
and ES10 dones were obtained, as previously  described  in detail (16, 
21), after doning under limiting dilution conditions. CD3-CD16 + 
responder cells were generated in MLC culture stimulated by ir- 
radiated PBL from a normal donor. These two clones specifically 
lyse PHA blasts carrying the NK cell aUospecificity  1. In the present 
study, the clones ES9 and ES10 were defrosted from a frozen stock 
and maintained in culture for "~ 1 mo in RPMI 1640 (Flow Labora- 
tories, Irvine, Scotland)  containing 10% FCS (Hyclone  Labs., Logan, 
UT),  100 U/ml rlL-2, and 10% Lymphocult-T-LF (Biotest AG, 
Dreieich, Germany). The dones were confirmed by indirect immu- 
nofluorescence (flow cytometry)  to be homogeneously CD16 + 
CD56+CD5-CD3 -  at the time of assays. 
Generation  of Polyclonal NK Cells.  PBMC from normal donors 
were obtained by Ficoll-Hypaque (F/H) density gradient and cocul- 
tivated with the y-irradiated B lymphoblastoid cell line RPMI 
8866 (23). After 8 d  of culture,  NK cell populations  (>95% 
CD3-CD5-CD16+CD56 +) were isolated by negative selection 
using anti-CD3,  -CD5,  and -CD14 antibodies and indirect im- 
munorosetting with CrC13-treated, goat  anti-mouse Ig-coated 
sheep erythrocytes (GotM-SRBC), as previously described (23). 
Cell Preparations.  PBL from 30 randomly chosen normal donors 
were isolated by F/H gradient and depleted of monocytes by plastic 
adherence (60 rain at 37~  PHA blasts were obtained by cul- 
turing PBL for 4 d with 5/xg/ml PHA (Sigma Chemical Co., St. 
Louis, MO) in the presence of rlL-2 (100 U/ml). Purification of 
PBHPC was performed as previously described (24), with some 
modification. Briefly,  light-density cells isolated from PBL on Per- 
coll gradient (d =  1.066) and depleted of T lymphocytes by roset- 
ting with 2-aminoethylisothiouronium bromide (Sigma Chemical 
Co.)-treated SRBC were incubated (45 min at 4~  with appropriate 
amounts of the following mAbs: OKT3 (anti-CD3), B36.1 (anti- 
CDS), B67.1 (anti-CD2), BC1 (anti-CD20), IV.3 (anti-CDw32), 
3G8 (anti-CD16), B159.5 (anti-CD56), B52.1 (anti-CD14), B13.4 
(antigranulocytes and antimonocytes), B59.2 (anti-CD41), and J5 
(anti-CD10). After three washes with cold IMDM (Gibco Labora- 
tories, Grand Island, NY), the cells were mixed with G~M-SRBC 
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cells, containing highly enriched populations of PBHPC (84--91% 
CD34+), were recovered after F/H density  gradient  centrifuga- 
tion.  In optimal culture conditions,  >30% of these cells formed 
hematopoietic colonies. A lower clonal efficiency ("~5%) was ob- 
served in the microculture system used in this study. The different 
cell fractions (PBL, PHA blasts, and PBHPC) were used immedi- 
ately or, in some instances, cryopreserved until used. 
Cytotoxicity Assay.  The cytolytic activity of the clone ES9 and 
ES10 or polyclonal NK cells was tested in a 4-h SlCr release assay 
using as target cells PHA blasts and PBHPC derived from the al- 
logeneic donors or the K562 cell line. Percent of specific lysis was 
determined  as previously described (25). 
Proliferation Assay.  Clone ES9 and ES10 NK cells were exten- 
sively washed and cultured  with or without "y-irradiated (5,000 
rad) PHA blasts derived from different allogeneic donors at a ratio 
of 5:1 for 48 h at 37~  in the absence or in the presence of rll~2 
(100 U/ml), rNKSF/IL-12 (1 ng/ml; Genetics Institute, Cambridge, 
MA), or rlL-2 plus rNKSF/IL-12. 6 h before harvesting, the cells 
were pulsed with [3H]Tdr (2 #Ci/well, 2 Ci/mmol; ICN Radio- 
chemical, Irvine, CA). The cells were collected on glass fiber filters, 
and [3H]TdR incorporation  was evaluated in a beta counter. 
IFN-9" and TNF-ot Induction Assay.  Clone ES9 and ES10 NK 
cells were incubated for 18 h with PHA blasts derived from the 
different allogeneic donors at a ratio of 5:1 in the absence or pres- 
ence of rlL-2 (100 U/ml) or rNKSF/IL-12 (1 ng/nl).  After incuba- 
tion, triplicate 50-/zl samples of ceU-free  supernatants were collected 
from each well and IFN-7 and TNF-c~ were measured by RIA as 
previously described (26, 27). 
Assay  for In Vitro Hematopoiesis.  PBHPC, resuspended with or 
without allogeneic polyclonal NK cells or ES9 and ES10 clones 
at different NK cell/PBHPC ratios (from 5:1 to 40:1) in IMDM 
containing 30% FCS, 10% BSA (Sigma Chemical Co.), 5  x  10 -s 
2-ME (Sigma Chemical Co.), 50 U/ml rlL-3, and 20 U/ml rGM- 
CSF (kindly provided by Dr. Steven Clark, Genetics Institute, Cam- 
bridge, MA) were centrifuged to allow cell-to-cell contact and then 
incubated for 6 h at 37~  5% CO2. In selected experiments,  a 
cocktail of neutralizing  antibodies against IFN-% (mAb B133.3, 
ascites), TNF-ot (mAb B154.2, ascites), and LT (polyclonal goat 
antiserum)  was added to the culture  at a final dilution  of 1:500. 
After  incubation  in liquid  suspension,  500-#1 aliquots  of 0.9% 
methylcellulose (Fluka Chemie AG, Buchs, Switzerland) containing 
500 PBHPC were seeded in triplicates in 24-weU  plates (Nunc, Inc. 
Naperville,  IL).  After 14 d of culture,  CFU-GM colonies were 
enumerated  in situ using  an inverted microscope. 
Statistical Analysis.  The data were analyzed using the STATS  ~ 
(StatSoft Inc., Tulsa, OK) statistical program. 
Results and Discussion 
The phenotype of 30 randomly chosen normal donors was 
determined by testing the susceptibility of their PHA blasts 
to the specificity 1 NK clones ES9 and ES10 in a SlCr re- 
lease cytotoxicity assay. 11 of 30 were found to be highly sus- 
ceptible to lysis mediated by both clones, and therefore ex- 
pressed  the  NK-recognized  allospecificity  1,  whereas  two 
displayed an intermediate phenotype. The degree of cytolysis 
(50-100% specific lysis at an E/T ratio of 5:1 for the suscep- 
tible donors, <20% for the resistant donors) and the expres- 
sion of the character  "susceptibility to lysis" by specificity 
1 NK clones in approximately one-third of the donors indi- 
cated a similar distribution  of the character  in the racially 
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heterogeneous population analyzed in this study compared 
to that originally reported in a more homogeneous popula- 
tion in previous studies (19). However, we also observed two 
donors  that  were  lysed  with  intermediate  susceptibility 
(20-50% specific lysis). Although this rare observation may 
not represent a true intermediate phenotype and may simply 
be due to heterogeneity in the susceptibility of the PHA blast 
preparations to the cytotoxic mechanisms mediated by NK 
cells, we cannot exclude the possibility that these donors may 
be indicative of a previously unrecognized phenotype, pos- 
sibly not present in the originally studied populations,  and 
suggesting a new level of complexity in the genetic control 
of the character "susceptibility to lysis" (18, 19). For all donors, 
allogeneic polyclonal NK cells did not lyse the PHA blast 
target cells even when pure preparations of activated NK cells 
were  used. 
We investigated  whether  specificity 1-susceptible PHA 
blasts, in addition to being sensitive to cell-mediated cytol- 
ysis, were also able to induce the NK clones to proliferate 
and produce cytokines, such as IFN-3~ and TNF-ot. Irradiated 
PHA blasts from representative susceptible donors (nos.  19 
and 23) and resistant individuals (nos. 22 and 24) were cul- 
tured with the ESIO clone in the absence or in the presence 
of rib2, rNKSF/IL-12, or a combination of the two cytokines. 
After a 48-h culture, proliferation was evaluated by [3H]TdR 
incorporation. As shown in Table 1, the allogeneic blasts did 
not elicit a mitogenic signal for the ES10 clones and did not 
significantly affect their proliferative response to rib2  and 
rNKSF/Ib12. The inability of NK cell clones after prolonged 
in vitro culture to respond to allogeneic cells with prolifera- 
tion, although they were still able to proliferate in response 
to mitogenic cytokines, contrasts with the observed in vitro 
expansion of alloreactive NK cells during  the initial  MLC 
and may be characteristic  of the stage of maturation/differenti- 
ation of the clonally expanded cells,  rNKSF/IL-12 by itself 
had a modest proliferative effect on the clone ES10 NK cells. 
As previously observed with polyclonal NK cells  (28, 29), 
NKSF/IL-12 mediated an antagonistic effect on the IL-2-driven 
proliferation  of the NK cells. 
We investigated the ability of specificity 1-susceptible PHA 
blasts to induce production  of IFN-'y and TNF-c~ by NK 
clones. PHA blasts from 11 representative donors were in- 
cubated 18 h with ES9 and ES10 clones (1.25  x  104/ml) at 
a ratio of 5:1 with or without rlL-2  or rNKSF/IL-12.  The 
results reported in Table 2 demonstrate that PHA blasts from 
specificity 1-susceptible donors induced ES9 and ES10 clones 
to produce IFN-y with increased production in the presence 
of rlL-2 and rNKSF/IL-12. PHA blasts from resistant donors 
or from an individual displaying an intermediate phenotype 
(e.g., donor no. 5) were ineffective in inducing IFN-3' produc- 
tion. In all five experimental conditions tested (ES9 or ES10 
clones, with or without cytokines),  PHA blasts from specificity 
1-susceptible donors induced significantly higher levels than 
PHA blasts from donors lacking  this  specificity (student's 
t test, p ~< 0.002). When the very low concentration of NK 
cells  (~104/ml)  used in  the  experiments  described in  this 
paper is considered,  the alloreactive NK cell clones appear 
particularly efficient in producing IFN-'y. In preliminary ex- Table  1.  Culture with Susceptible or Resistant PHA Blasts Does Not Influence the Proliferation of Clone ESIO NK Cells 
PHA blasts from donor 
Cytokines  None  No.  19  (73%)  No.  22  (0%)  No.  23  (72%)  No.  24  (1%) 
cpm 
None  388  424  442  426  419 
rlL-2 (100 U/ml)  1,596  1,749  1,688  1,632  1,438 
rNKSF/IL-12 (1  ng/ml)  668  971  595  682  585 
rlL-2  +  rNKSF/IL-12  638  800  229  608  901 
Alloreactive (specificity 1) NK cells (clone ESIO) were incubated for 48 h in medium supplemented or not with rlL-2, rNKSF/IL-12, or both cytokines 
and in the presence or absence of irradiated PHA blasts from four different donors, two of which (nos. 19 and 23) were susceptible to lysis  by ES10 
cells and two (nos. 22 and 24) that were resistant (percent SlCr release at 5:1 E/T ratio is indicated in parentheses after the donor number). Data 
are [3H]TdR uptake measured after a 6-h pulse. 
periments with a small number of donors, it was observed 
that not only PHA blasts, but also resting PBL from specifidty 
1-susceptible donors, induced the alloreactive NK clones to 
produce IFN-3' (not shown). This finding suggests that the 
molecule(s) engaged upon allospecific NK-mediated recog- 
nition may be involved in the delivery of intracellular signals 
leading to  IFN-y production. Low titers of TNF-o~ (<5 
U/ml) were also found in the supernatant fluid of cultures 
of ES9 and ES10 cells with sensitive PHA blasts, in the pres- 
ence of rib2  or rNKSF/IL-12  (data not shown). 
We tested whether the specificities  recognized by the human 
alloreactive clones are expressed on hematopoietic progen- 
itor  cells, similarly  to  the putative Hh  determinants, by 
analyzing whether the colony formation in semisolid medium 
by PBHPC from the specificity 1-susceptible donors was in- 
hibited by clone ES9 and ESIO NK cells. Fig.  1 illustrates 
two experiments with one susceptible and one resistant donor 
at different E/T cell ratios,  whereas Fig. 2 summarizes the 
results of all experiments. Polyclonal NK cells, as previously 
reported (30), only partially inhibited peripheral blood my- 
Table  2.  Clone  ES9 and ESIO NK Cells Produce IFN-'f in Response to PHA Blasts from Specificity I-susceptible Donors 
ES9 done  ES10 clone 
PHA blasts  Percent  Percent 
from donor:  SlCr release  Medium  rlL-2  SlCr release  Medium  rlL-2  rNKSF/IL-12 
U/ml  U/ml 
None  NA*  3  4  NA  <1  2  3 
1  53  13  26  74  19  25  39 
2  77  23  39  76  31  50  70 
3  95  13  23  100  25  30  44 
4  12  2  3  6  5  7  6 
5  33  2  4  30  3  4  5 
6  74  18  24  68  20  28  27 
7  7  7  5  8  <1  6  4 
8  89  12  14  77  7  25  17 
9  4  5  4  6  2  3  6 
10  6  5  6  13  <1  7  4 
11  7  2  5  6  3  9  6 
Alloreactive (specificity 1) NK cell clones were tested for their cytotoxicity against PHA blasts from donor 1-11 and for the ability to produce IFN-3, 
when cultured with the same PHA blasts. Cytotoxicity was tested in a 4-h slCr release assay in medium at a 5:1 E/T cell ratio.  IFN-3, was meas- 
ured by RIA in the cell-free supernatant fluids collected from 18-h cultures  of NK clones (1.25  x  104/ml) and PHA blasts (0.25  x  104/ml) in 
medium or in the presence of rlL-2 (100 U/ml) or rNKSF/IL-12 (1 ng/ml). PHA blasts alone did not produce  detectable IFN-% 
* NA, not applicable. 
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Figure  1.  Inhibition of CFU-GM formation by polyclonal  NK cells 
and alloreactive (specificity  1) NK cells clones.  PBHPC (500/well in the 
presence of IL-3 and GM-CSF)  from donor nos. 2 and 4, susceptible and 
resistant,  respectively,  to  specificity  1 NK cell  clones,  were  tested  for 
CFU-GM formation in the presence of polyclonal  NK cells (O) or ES9 
(A) and ES10 (V) allospecific  NK clones  at the indicated  NK cells  to 
PBHPC ratios.  Data are average  +  SD of triplicate  determinations. 
eloid colony formation from either susceptible or resistant 
donors even at an E/T ratio of 40:1. ES9 and ES10 NK clones 
at an E/T  ratio of 10:1 significantly  and often completely 
abrogated  CFU-GM growth from donor nos. 1, 2, 3, 6, and 
23 carrying the specificity I susceptibility phenotype, but did 
not significantly affect colony growth from resistant  donor 
has. 4, 20, 21, 22, 24, and 25 (Fig. 2 B). A significant corre- 
lation was observed between the sensitivity of PHA blasts 
to the cytotoxic effect of the alloreactive  NK cells and the 
sensitivity of CFU-GM derived from PBHPC from the same 
donors to the inhibitory effect of the clones (Fig. 2 C). Both 
PHA blasts and PBHPC from donor no. I displayed a some- 
what lower sensitivity to both ES9 and ES10 clones than cells 
from other specificity  1-susceptible donors.  Although  this 
reduced sensitivity might simply be due to experimental or 
individual  variability, this donor might also represent another 
case of an intermediate phenotype, as discussed above. A one- 
way analysis of variance of these data, utilizing observed colony 
numbers, showed that the presence  or absence of specificity 
1 significantly  affected inhibition of PBHPC by the ES9 clone 
(F  =  21.47, p  =  0.004),  but not the inhibition by poly- 
clonal  NK cells  (F  =  2.74,  NS). 
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Figure  2.  Sensitivity  of PHA blasts and PBHPC to alloreactive NK 
cells.  (A) Clones ES9 and ES10 were tested  in a 4-h SlCr release assay 
against slCr-labeled PHA blasts (E/T ratio 5:1) from 11 different donors. 
(B) PBHPC from the same 11 donors were tested for CFU-GM formation 
in the presence or absence of polyclonal NK cells (NK cells/PBHPC ratio 
40:1) or clones  ES9 and ES10 NK (ratio 10:1). Results  are expressed as 
percent inhibition of CFU-GM formation in the presence of NK cells com- 
pared with PBHPC cultures without NK cells. (C) Correlation  between 
cell-mediated cytotoxicity (ES9 clone) of PHA blasts and inhibition (ES10 
clone)  of CFU-GM formation by PBHPC  from the same donors. 
The finding that PHA blasts from susceptible donors were 
able to induce the NK clones to produce high amounts of 
IFN-~/and, to a lesser extent, TNF-c~, factors having a syner- 
gistic suppressor effect on in vitro hemopoiesis (31), prompted 
us to verify whether such cytokines were responsible for the 
observed colony growth inhibition, Hematopoietic progen- 
itor assays were performed in the absence  or presence of a 
mixture of neutralizing antibodies,  anti-IFN-'y,  -TNF-c~, and 
-LT. As shown in Fig. 3, these antibodies had only a minimal 
effect on the ability of the ES10 clone to inhibit CFU-GM 
from donors carrying specificity 1, whereas they completely 
blocked  the inhibitory  activity  of polyclonal  NK  cells on 
PBHPC  from  all  four  donors  shown.  When  specificity 
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Figure 3.  Role of cytokines in the inhibition of CFU-GM formation 
by polyclonal  NK cells and alloreactive  NK cell clones. Colony formation 
by PBHPC (500/well in the presence of IL-3 and GM-CSF) from donor 
no. 23, susceptible  to specificity  1 NK cell clones, and from resistant donor 
nos. 24, 21, and 20 was measured in medium (striped bars) or in the pres- 
ence of a mixture of anti-TNFot, -LT, and -IFN-3, antibodies (open ban). 
No NK cells (Medium), polyclonal NK cells (NK), or cells of the ES10 
NK clone (ESIO) (5  ￿  103/well) were added to the indicated cultures. 
In the indicated cultures containing PBHPC and ES10 cells, PHA blasts 
(1,000 cells/well) from NK allospecificity  1-positive [blasts (+)] or nega- 
tive [blasts (-)] donors were also added. Results are expressed as average 
+ SD from triplicate experiments. The number in parentheses under the 
donor number indicates the percent 51Cr release obtained when a cyto- 
toxic assay was performed using clone ES9 effector cells and PHA blasts 
from the indicated donors as target cells (E/T ratio 5:1). These results 
are representative of six donors tested. 
1-susceptible and -resistant  PHA blasts  [Fig.  3,  blasts  (+) 
and blasts (-),  respectively] were added to the culture of al- 
loreactive NK clones with PBHPC, a partial to complete in- 
hibition of specificity 1-resistant PBHPC was observed when 
PHA blasts from susceptible, but not resistant donors, were 
added (Fig. 3  illustrates  the results obtained with PBHPC 
from three representative specificity 1-resistant donor: nos. 
20,  21,  and 24).  Unlike  the inhibitory effect of ES10 cells 
on specificity 1-susceptible PBHPC from donor nos. 23, the 
inhibition of specificity 1-resistant PBHPC (donor no.  20, 
21, and 24) in the presence of bystander specificity 1-susceptible 
PHA blasts (blasts [+]) was completely prevented by the an- 
tibodies  against  IFN-y,  TNF-ot,  and  LT. 
These  results  suggest  that  the  inhibition  of specificity 
1-susceptible PBHPC by alloreactive NK cell clones could 
be mostly due to a direct cytotoxic effect of the NK cells 
on the hematopoietic progenitor cells. To directly test this 
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Sensitivity of PHA blasts and PBHPC to the cytotoxic ac- 
tivity mediated by ES10 alloreactive  NK cell clones. Cells from the ES10 
NK clone were used as effector cells (E/T ratio 4:1) against SlCr-labeled 
K562 cells or PHA blasts and PBHPC from donor nos. 33, 35, and 36, 
susceptible to specificity  1 NK clones and donor nos. 34, and 38, specificity 
1 resistant, in a 4-h 51Cr release assay. 
hypothesis,  we  analyzed  the  ability  of clone ES10  to  lyse 
5*Cr-labeled  PHA  blasts  and  PBHPC  from  five different 
donors, three positive and two negative for specificity 1. As 
shown in Fig.  4, ES10 at an E/T ratio of 4:1 lysed >60% 
of both PHA blasts and PBHPC from the three susceptible 
donors, whereas PHA blasts and PBHPC from the two resis- 
tant donors were lysed at a much lower level. In particular, 
>90%  of PBHPC  from susceptible donor nos.  35  and  36 
were  lysed  by  ES10  cells.  Because  >80%  of PBHPC  are 
CD34 + and >30% of them form hematopoietic colonies in 
vitro, these data are consistent with the hypothesis that the 
alloreactive NK cells can lyse hematopoietic precursor cells 
from specificity 1-susceptible donors. In the same experimental 
conditions, activated polyclonal NK cells were unable to lyse 
either PHA blasts  or PBHPC. 
The  data  presented  in  this  paper  demonstrate  that  the 
specificity recognized by alloreactive NK cell clones is ex- 
pressed not only on lectin-activated T  lymphocytes or EBV- 
transformed B cells, as originally described (16, 21), but also 
on resting PBHPC and probably other hematopoietic cells. 
The specificity of alloreactive NK cells is likely determined 
by a pattern of class  I  MHC  antigen  expression on target 
cells that  determines resistance or susceptibility to lysis by 
different NK cell clones (21). The ability of PBHPC to be 
recognized specifically by alloreactive NK cells suggests that, 
similarly to mature cells, they efficiently express the class I 
MHC antigens that prevent lysis by the alloreactive NK cell 
clones with an inappropriate specificity. These data contrast 
with the hypothesis that the reactivity of NK cells with he- 
matopoietic progenitor cells reflects a proposed function of 
NK cells in the surveillance against  primitive cells (32) by 
possibly recognizing low or absent class I MHC expression 
(7).  However, the ability of autologous or allogeneic poly- 
clonal NK cells to affect proliferation of progenitor cells, a 
phenomenon mostly due to secretion of inhibitory cytokines 
(30, 33), may differ from the ability of alloreactive NK cell 
1122  Alloreactive  Natural Killer Cell Clones and Hematopoiesis clones to inhibit colony formation with a mechanism that 
suggests a direct cytotoxic effect, and the physiologic rele- 
vance of each of these phenomena remains to be determined. 
The ability of PHA blasts from specificity 1-susceptible 
donors to specifically stimulate the production of IFN-3' and 
other lymphokines from specificity 1-alloreactive  NK  cell 
clones demonstrates that resistant  target cells are not only 
unable to be lysed or to trigger the cytotoxic machinery in 
NK cells, but also fail to induce the signal transduction mech- 
anism leading to lymphokine production. If the hypothesis 
that resistance of target ceils to lysis is due to a negative signal 
delivered to the NK cells by class I MHC antigens on target 
cells is correct, then these results indicate that this negative 
signal affects not only cytotoxicity, but also the signaling 
pathways leading to both cytotoxicity and lymphokine produc- 
tion. Antibodies against TNF-ot, IFN-% and LT, the cytokines 
most commonly involved in the inhibition of hematopoiesis 
by lymphocytes (26, 33), only minimally (,020%) prevented 
the inhibition of CFU-GM by alloreactive NK cells. These 
results  and  the  finding  that  the  alloreactive  NK  clones 
efficiently lyse highly enriched preparations of PBHPC are 
consistent with the hypothesis that these NK cells mostly 
act via a direct cytotoxic effect on the progenitor cells. How- 
ever, because the PBHPC preparations used in this study are 
not completely pure, the possibility of an indirect effect of 
the alloreactive NK cells can not be excluded. By contrast, 
aUoreactive NK cell clones can at least partially inhibit PBHPC 
from resistant donors when bystander PHA blasts from sus- 
ceptible donors are present and this inhibition is completely 
reversed by anticytokine antibodies. Therefore, in this latter 
system, the mechanism of inhibition of PBHPC by alloreac- 
tive NK cell clones appears to be analogous to that mediated 
by autologous and allogeneic polyclonal NK cells at much 
higher E/T ratios. The mechanism of induction of cytokine 
production in polyclonal NK  cell preparations is not well 
characterized and the question of whether the progenitor cells 
themselves or other cell types present in enriched progenitor 
cell preparations  are responsible for their induction is  still 
an open question (30,  33). 
In the mouse, in vitro models for hybrid resistance have 
been difficult to establish.  NK cell preparations have been 
shown to inhibit hematopoietic colony formation in vitro 
in the strain combinations incompatible for Hh-1, but at levels 
only marginally higher than those observed in syngeneic com- 
binations (22). Fresh or activated NK cells from athymic rats 
lyse and inhibit colony formation by allogeneic hematopoi- 
etic progenitor cells,  but stimulated syngeneic hematopoi- 
esis (34). Although crosscompetition experiments have shown 
that allodeterminants coded for by single MHC haplotypes 
are responsible for the specificity of alloreactive rat NK cells 
(35), the experimental systems using polyclonal NK cell cul- 
tures offer a limited ability to investigate the fine specificity 
of NK cell recognition. The development of human alloreactive 
NK clones has offered new opportunities for the understanding 
of the mechanism of target cell recognition by NK cells, and 
important information has already been provided by this ex- 
perimental system. Our present results show that human NK 
cell alloreactivity is probably the human counterpart of the 
mouse and rat hybrid resistance phenomenon. Because of the 
high efficiency of alloreactive NK cells to mediate cytotox- 
icity and cytokine release,  it is possible that they play a role 
in the rejection of clinical allogeneic bone marrow transplants, 
that, in at least a few cases, has been shown to be mediated 
by host NK cells  (36, 37).  More importantly, however, al- 
loreactive NK ceils of donor origin might be involved in the 
graft-vs.-leukemia reaction in transplanted patients. It has been 
reported  that  a  proportion  of transplanted  patients  with 
chronic myelogenous leukemia develop IL-2-activatable NK 
cells that lyse autologous and allogeneic leukemia cells with 
an intriguing pattern of selectivity that is reminiscent of that 
seen for alloreactive NK cell clones (38). It is of interest that 
the relapse rate is much lower in the patients developing this 
cytotoxic activity than in those not developing it (92.8% re- 
lapse free at 3 yr vs.  28.3%)  (38).  A  better knowledge of 
the mechanism and specificity of alloreactive NK cell clones 
may therefore not only provide us with a better understanding 
of the regulation of the natural resistance mechanism, but 
may also provide information of clinical relevance that could 
lead to therapeutic attempts to modulate the activity of these 
cytotoxic cells or their use in adoptive transfer. 
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